An investigation has backed the British Medical Journal’s handling of two controversial and inaccurate articles it published on the harms of cholesterol-reducing statins. Both claimed that 20% of users would suffer harmful side effects. The journal withdrew the claim, but refused calls for a full retraction. Yet prominent academics have criticised the investigation, saying the […]
↧